Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|March 21, 2017
Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based studyHenrik Cederleuf, Lasse Hjort Jakobsen, Fredrik Ellin, et al.
American Journal of Hematology|June 1, 2010
Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samplesUlrika Andréasson, Patrik Edén, Carsten Peterson, et al.
British Journal of Haematology|April 25, 2022
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patientsSara Harrysson, Sandra Eloranta, Sara Ekberg, et al.
British Journal of Haematology|March 9, 2021
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factorsJoana M Rodrigues, Anna Nikkarinen, Peter Hollander, et al.
Haematologica|December 15, 2022
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factorsAnna Sandström Gerdtsson, Joana de Matos Rodrigues, Christian Winther Eskelund, et al.
The Lancet. Haematology|November 29, 2023
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approachPeter Dreger, Paolo Corradini, John G Gribben, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group StudyJorne L Biccler, Sandra Eloranta, Peter de Nully Brown, et al.
Leukemia & Lymphoma|October 11, 2007
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTENMarie Fridberg, Anna Servin, Lola Anagnostaki, et al.
Cancers|July 13, 2024
Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of PatientsLavanya Lokhande, Daniel Nilsson, Joana de Matos Rodrigues, et al.
British Journal of Haematology|February 6, 2016
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational studyLasse H Jakobsen, Martin Hutchings, Peter de Nully Brown, et al.
Pageof 17